urea has been researched along with Colorectal Cancer in 21 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Excerpt | Relevance | Reference |
---|---|---|
"Dysregulation of the urea cycle (UC) has been detected in colorectal cancer (CRC)." | 8.84 | Association between serum urea concentrations and the risk of colorectal cancer, particularly in individuals with type 2 diabetes: A cohort study. ( Chen, X; Gao, P; Jiang, Y; Liu, Z; Mei, Z; Suo, C; Xu, K; Yuan, H; Zhang, T; Zhao, R; Zhu, D, 2024) |
"Urea cycle activity in colorectal cancer is associated with the absence of ureolytic gut bacteria." | 8.31 | Microbiome Imbalance Promotes Colorectal Cancer via Urea Cycle Activation. ( , 2023) |
"Here, we show that colorectal cancers (CRCs) display negligible expression of OTC and, in subset of cases, ASS1 proteins." | 5.48 | Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. ( Al-Aqbi, SS; Alexandrou, C; Andreadi, C; Blades, M; Boyle, W; Brown, K; Cheng, PN; Higgins, JA; Howells, LM; Karmokar, A; Luo, JL; Moore, DA; Murray, GI; Rufini, A; Thomas, A; Viskaduraki, M, 2018) |
"Irinotecan (Campto, Rhône-Poulenc Rorer) is probably the most studied drug used as second-line treatment for colorectal cancer." | 5.09 | Colorectal cancer: dilemmas regarding patient selection and toxicity prediction. ( Jelic, S; Nikolic-Tomasevic, Z; Popov, I; Radosavljevic, D, 2000) |
"Dysregulation of the urea cycle (UC) has been detected in colorectal cancer (CRC)." | 4.84 | Association between serum urea concentrations and the risk of colorectal cancer, particularly in individuals with type 2 diabetes: A cohort study. ( Chen, X; Gao, P; Jiang, Y; Liu, Z; Mei, Z; Suo, C; Xu, K; Yuan, H; Zhang, T; Zhao, R; Zhu, D, 2024) |
"Urea cycle activity in colorectal cancer is associated with the absence of ureolytic gut bacteria." | 4.31 | Microbiome Imbalance Promotes Colorectal Cancer via Urea Cycle Activation. ( , 2023) |
"Finally, several agents may prevent colorectal cancer through prevention of the formation of colorectal polyps (eg, cyclooxygenase inhibitors)." | 2.40 | Promising new agents for treatment of patients with colorectal cancer. ( Von Hoff, DD, 1998) |
"Here, we show that colorectal cancers (CRCs) display negligible expression of OTC and, in subset of cases, ASS1 proteins." | 1.48 | Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. ( Al-Aqbi, SS; Alexandrou, C; Andreadi, C; Blades, M; Boyle, W; Brown, K; Cheng, PN; Higgins, JA; Howells, LM; Karmokar, A; Luo, JL; Moore, DA; Murray, GI; Rufini, A; Thomas, A; Viskaduraki, M, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 5 (23.81) | 24.3611 |
2020's | 9 (42.86) | 2.80 |
Authors | Studies |
---|---|
Lv, Q | 1 |
Pan, X | 1 |
Wang, D | 1 |
Rong, Q | 1 |
Ma, B | 1 |
Xie, X | 2 |
Zhang, Y | 3 |
Wang, J | 1 |
Hu, L | 2 |
Wu, CF | 1 |
Wang, QC | 1 |
Chen, R | 1 |
Zhou, HL | 1 |
Wu, TT | 1 |
Du, Y | 1 |
Zhang, NN | 1 |
Zhang, HM | 1 |
Fan, ZY | 1 |
Wang, LL | 1 |
Hu, CJ | 1 |
Sang, ZP | 1 |
Li, HL | 1 |
Wang, L | 1 |
Tang, L | 1 |
Zhang, JQ | 1 |
Meng, X | 1 |
Peng, J | 1 |
Yu, F | 1 |
Wang, W | 1 |
Pan, Q | 1 |
Jin, H | 1 |
Huang, X | 1 |
Yu, H | 1 |
Li, S | 1 |
Feng, D | 1 |
Liu, Q | 1 |
Fang, L | 1 |
Lee, MH | 1 |
Brezmes, J | 1 |
Llambrich, M | 1 |
Cumeras, R | 1 |
Gumà, J | 1 |
Gao, P | 1 |
Mei, Z | 1 |
Liu, Z | 1 |
Zhu, D | 1 |
Yuan, H | 1 |
Zhao, R | 1 |
Xu, K | 1 |
Zhang, T | 2 |
Jiang, Y | 1 |
Suo, C | 1 |
Chen, X | 1 |
Torrente, L | 1 |
Maan, G | 1 |
Oumkaltoum Rezig, A | 1 |
Quinn, J | 1 |
Jackson, A | 1 |
Grilli, A | 1 |
Casares, L | 1 |
Kulesskiy, E | 1 |
Saarela, J | 1 |
Bicciato, S | 1 |
Edwards, J | 1 |
Dinkova-Kostova, AT | 1 |
de la Vega, L | 1 |
Tang, JF | 1 |
Xu, H | 1 |
Tian, K | 1 |
Wu, MN | 1 |
Huang, SY | 1 |
Du, YM | 1 |
Zhou, P | 1 |
Lu, RJ | 1 |
He, S | 1 |
Xu, JM | 1 |
Si, JJ | 1 |
Li, J | 1 |
Chen, DL | 1 |
Ran, JH | 1 |
Long, Y | 1 |
Sanchez-Espiridion, B | 1 |
Lin, M | 1 |
White, L | 1 |
Mishra, L | 1 |
Raju, GS | 1 |
Kopetz, S | 1 |
Eng, C | 1 |
Hildebrandt, MAT | 1 |
Chang, DW | 1 |
Ye, Y | 1 |
Liang, D | 1 |
Wu, X | 1 |
Alexandrou, C | 1 |
Al-Aqbi, SS | 1 |
Higgins, JA | 1 |
Boyle, W | 1 |
Karmokar, A | 1 |
Andreadi, C | 1 |
Luo, JL | 1 |
Moore, DA | 1 |
Viskaduraki, M | 1 |
Blades, M | 1 |
Murray, GI | 1 |
Howells, LM | 1 |
Thomas, A | 1 |
Brown, K | 1 |
Cheng, PN | 1 |
Rufini, A | 1 |
Li, L | 1 |
Chen, Q | 1 |
Yu, Y | 1 |
Chen, H | 1 |
Lu, M | 1 |
Huang, Y | 1 |
Li, P | 1 |
Chang, H | 1 |
Tan, B | 1 |
Qiu, Y | 2 |
Zou, X | 1 |
Chen, T | 2 |
Xie, G | 1 |
Cheng, Y | 1 |
Dong, T | 1 |
Zhao, L | 1 |
Feng, B | 1 |
Hu, X | 1 |
Xu, LX | 2 |
Zhao, A | 2 |
Zhang, M | 1 |
Cai, G | 2 |
Cai, S | 2 |
Zhou, Z | 1 |
Zheng, M | 1 |
Jia, W | 2 |
Zhang, B | 1 |
Dong, S | 1 |
Zhu, R | 1 |
Hu, C | 1 |
Hou, J | 1 |
Li, Y | 1 |
Zhao, Q | 1 |
Shao, X | 1 |
Bu, Q | 1 |
Li, H | 1 |
Wu, Y | 1 |
Cen, X | 1 |
Zhao, Y | 1 |
Su, M | 1 |
Zheng, X | 1 |
Xu, Y | 1 |
Ni, Y | 1 |
Farooq, N | 1 |
Patterson, AJ | 1 |
Walsh, SR | 1 |
Prytherch, DR | 1 |
Justin, TA | 1 |
Tang, TY | 1 |
Lauwaet, T | 1 |
Oliveira, MJ | 1 |
Callewaert, B | 1 |
De Bruyne, G | 1 |
Saelens, X | 1 |
Ankri, S | 1 |
Vandenabeele, P | 1 |
Mirelman, D | 1 |
Mareel, M | 1 |
Leroy, A | 1 |
Chen, YL | 1 |
Jong, YJ | 1 |
Ferrance, J | 1 |
Hsien, JS | 1 |
Shih, CJ | 1 |
Feng, CH | 1 |
Wu, MT | 1 |
Wu, SM | 1 |
Deehan, DJ | 1 |
Heys, SD | 1 |
Broom, J | 1 |
Eremin, O | 1 |
Whiting, PH | 1 |
Von Hoff, DD | 1 |
Nikolic-Tomasevic, Z | 1 |
Jelic, S | 1 |
Popov, I | 1 |
Radosavljevic, D | 1 |
del Ara, RM | 1 |
González-Polo, RA | 1 |
Caro, A | 1 |
del Amo, E | 1 |
Palomo, L | 1 |
Hernández, E | 1 |
Soler, G | 1 |
Fuentes, JM | 1 |
2 reviews available for urea and Colorectal Cancer
Article | Year |
---|---|
Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer.
Topics: Acetates; Acetone; Biomarkers; Carnitine; Colorectal Neoplasms; Creatinine; Glucose; Humans; Lysine; | 2022 |
Promising new agents for treatment of patients with colorectal cancer.
Topics: Adenoviridae; Antineoplastic Agents; Benzofurans; Colorectal Neoplasms; Drug Screening Assays, Antit | 1998 |
2 trials available for urea and Colorectal Cancer
Article | Year |
---|---|
Renal impairment associated with the pre-operative administration of recombinant interleukin-2.
Topics: Acetylglucosaminidase; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Creatinine; Female; gam | 1994 |
Colorectal cancer: dilemmas regarding patient selection and toxicity prediction.
Topics: Adult; Antineoplastic Agents, Phytogenic; Blood Proteins; Camptothecin; Colorectal Neoplasms; Creati | 2000 |
17 other studies available for urea and Colorectal Cancer
Article | Year |
---|---|
Discovery of (
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemotaxis; Colorectal Neopl | 2021 |
Synthesis and bioevaluation of diaryl urea derivatives as potential antitumor agents for the treatment of human colorectal cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasm | 2022 |
Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression.
Topics: Animals; Colorectal Neoplasms; Humans; MicroRNAs; Polyamines; RNA, Long Noncoding; Tumor Suppressor | 2022 |
Microbiome Imbalance Promotes Colorectal Cancer via Urea Cycle Activation.
Topics: Bacteria; Colorectal Neoplasms; Humans; Microbiota; Urea | 2023 |
Association between serum urea concentrations and the risk of colorectal cancer, particularly in individuals with type 2 diabetes: A cohort study.
Topics: Cohort Studies; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Humans; Risk Factors; Urea | 2024 |
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro.
Topics: Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Eval | 2020 |
Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
Topics: Animals; Biomarkers; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neopla | 2021 |
Global and targeted serum metabolic profiling of colorectal cancer progression.
Topics: Adenoma; Adult; Aged; Caffeine; Case-Control Studies; Chromatography, Liquid; Colonic Polyps; Colore | 2017 |
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Arginase; Arginine; Argininosuccinate | 2018 |
RKI-1447 suppresses colorectal carcinoma cell growth via disrupting cellular bioenergetics and mitochondrial dynamics.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasm | 2020 |
Metabonomics identifies serum metabolite markers of colorectal cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoembryonic Antigen; Case-Control Studies; Citric Acid Cycle; C | 2013 |
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Topics: Animals; Arginine; Cell Proliferation; Colorectal Neoplasms; Female; Gene Knockdown Techniques; HCT1 | 2015 |
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Topics: Adult; Aged; Amino Acids; Colorectal Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Humans | 2009 |
Predicting outcome following colorectal cancer surgery using a colorectal biochemical and haematological outcome model (Colorectal BHOM).
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Forecasting; Humans; Logi | 2011 |
Proteolysis of enteric cell villin by Entamoeba histolytica cysteine proteinases.
Topics: Animals; Carrier Proteins; Cell Adhesion; Coculture Techniques; Colorectal Neoplasms; Cysteine Endop | 2003 |
Single nucleotide polymorphism detection in the hMSH2 gene using conformation-sensitive CE.
Topics: Base Sequence; Case-Control Studies; Colorectal Neoplasms; DNA Primers; DNA, Neoplasm; Electrophores | 2008 |
Diagnostic performance of arginase activity in colorectal cancer.
Topics: Arginase; Biological Assay; Biomarkers, Tumor; Biopsy; Carcinoma; Colorectal Neoplasms; Enzyme Stabi | 2002 |